What You Need to Know About Pre- and Post-Surgery Compliance
Rick Redner discusses his experiences living with Prostate Cancer and the details about Pre- and Post-Surgery Compliance. Read more.
Active Surveillance May Increase Likelihood of Adverse Outcomes in Low-Volume Intermediate-Risk Prostate Cancer
Active surveillance may expose men with intermediate-risk prostate cancer to adverse outcomes that could be avoided by immediate intervention, according... Read More
Men with Both Prostate and Other Cancers May Be Slipping Through Genetic Screening Crack, Study Finds
Men with both prostate and other cancers may be falling through a genetic screening crack that could have flagged the... Read More
Men with Both Prostate and Other Cancers May Be Slipping Through Genetic Screening Crack, Study Finds
Men with both prostate and other cancers may be falling through a genetic screening crack that could have flagged the... Read More
Neolys Develops Blood Test to Help Doctors Decide Radiotherapy Levels for Prostate Cancer
Neolys Diagnostics has developed a blood test to measure patients’ sensitivity to radiation before they receive radiation therapy, a common prostate cancer treatment. Read... Read More
Trial of Miltuximab in Prostate, Other Cancers Gets Nod to Enroll Additional Patients
The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, bladder, and... Read More
FDA Requests More Data After Reviewing IsoRay’s Application for GammaTile Radiation Therapy
IsoRay, a company specializing in the treatment of prostate and other cancers, has received a response from the U.S. Food... Read More
Half of Urologists Unaware of New, More Sensitive Prostate Cancer Tests, Survey Shows
Half of urologists are unaware of newer, more sensitive biomarker tests for detecting prostate cancer, according to a survey of... Read More
GRHL2 Protein Has Dual Role in Prostate Cancer, Researchers Find
Researchers at the University of Adelaide in Australia have found that Grainyhead-like protein 2, called GRHL2, plays a dual role... Read More
4 Reasons It’s Difficult to Choose Among Treatment Options
Rick Redner discusses his experience with prostate cancer and why men struggle to choose among treatment options. Read more.